|Articles|May 7, 2004
Sales growth boosts Alcon earnings 46.7%
Almost everything clicked for Alcon Inc. during the first quarter of 2004, as the company recorded global sales of $963.6 million, an increase of 19.4% from the first quarter of 2003.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
2
AAO 2025: Advancements in laser refractive surgery
3
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
4
From then to next: Five decades of transformation in ophthalmology
5














































.png)


